The selection or procurement of blood collection devices in healthcare facilities is often an underestimated issue. This is probably due to different factors including the lack of knowledge of policymakers, hospital administrators and even laboratory managers about the importance of preanalytical quality and phlebotomy process, as well as to the absence of reliable guidelines or recommendations on how to precisely assess the quality of blood collection devices around the globe. With the awareness that a gap remains between manufacturers' and local validation of blood collection devices, the Working Group for Preanalytical Phase (WG-PRE) of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) has drafted a consensus document aimed to provide a set of essential requisites, technical criteria (e.g. presence of physical defects, malfunctioning, safety problems) and clinical issues for supporting laboratory professionals in organization blood collection tubes tenders and validating new devices before local routine implementation. The laboratory professionals should also make sure that the tenders accurately and strictly define the responsibilities for validation experiments and the potential consequences in the case the validation outcome shows that tubes due not fulfill the expectations.
CITATION STYLE
Lippi, G., Cornes, M. P., Grankvist, K., Nybo, M., & Simundic, A. M. (2016). EFLM WG-Preanalytical phase opinion paper: Local validation of blood collection tubes in clinical laboratories. Clinical Chemistry and Laboratory Medicine, 54(5), 755–760. https://doi.org/10.1515/cclm-2015-1274
Mendeley helps you to discover research relevant for your work.